Immix Biopharma (IMMX) Competitors

CARGO Therapeutics (NASDAQ:CRGX) and Immix Biopharma (NASDAQ:IMMX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability, community ranking and analyst recommendations.

Do analysts prefer CRGX or IMMX?

CARGO Therapeutics presently has a consensus target price of $15.00, suggesting a potential upside of 246.02%. Immix Biopharma has a consensus target price of $7.00, suggesting a potential upside of 233.33%. Given CARGO Therapeutics' higher possible upside, equities analysts clearly believe CARGO Therapeutics is more favorable than Immix Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CARGO Therapeutics	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Immix Biopharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is CRGX or IMMX more profitable?

CARGO Therapeutics' return on equity of -38.16% beat Immix Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CARGO Therapeutics	N/A	-38.16%	-33.94%
Immix Biopharma	N/A	-102.68%	-80.89%

Does the MarketBeat Community believe in CRGX or IMMX?

CARGO Therapeutics received 3 more outperform votes than Immix Biopharma when rated by MarketBeat users. However, 100.00% of users gave Immix Biopharma an outperform vote while only 66.67% of users gave CARGO Therapeutics an outperform vote.

Company	Underperform	Outperform
CARGO Therapeutics	Outperform Votes 14 66.67%	Underperform Votes 7 33.33%
Immix Biopharma	Outperform Votes 11 100.00%	Underperform Votes No Votes

Do insiders and institutionals hold more shares of CRGX or IMMX?

93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 11.3% of Immix Biopharma shares are held by institutional investors. 1.4% of CARGO Therapeutics shares are held by insiders. Comparatively, 48.9% of Immix Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has more risk and volatility, CRGX or IMMX?

CARGO Therapeutics has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, Immix Biopharma has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.

Which has stronger valuation and earnings, CRGX or IMMX?

Immix Biopharma is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CARGO Therapeutics	N/A	N/A	-$98.15M	-$3.72	-1.17
Immix Biopharma	N/A	N/A	-$15.43M	-$0.77	-2.73

Does the media favor CRGX or IMMX?

In the previous week, Immix Biopharma had 2 more articles in the media than CARGO Therapeutics. MarketBeat recorded 3 mentions for Immix Biopharma and 1 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.70 beat Immix Biopharma's score of 1.19 indicating that CARGO Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
CARGO Therapeutics	Very Positive
Immix Biopharma	Positive

Summary

CARGO Therapeutics beats Immix Biopharma on 8 of the 15 factors compared between the two stocks.